These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7759983)

  • 1. Characterization of induced pulpal hypoxia using 3H-misonidazole.
    Baumgardner KR; Osborne JW; Walton RE; Born JL
    J Endod; 1994 Dec; 20(12):585-8. PubMed ID: 7759983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention.
    Baumgardner KR; Walton RE; Osborne JW; Born JL
    J Dent Res; 1996 Oct; 75(10):1753-60. PubMed ID: 8955670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and excretion of [3H]misonidazole by hypoxic rat liver.
    Smith BR; Born JL
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1365-70. PubMed ID: 6469758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse.
    Cobb LM; Nolan J; Butler S
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):347-51. PubMed ID: 2303365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of misonidazole in normal and malignant tissues: interplay of hypoxia and reductases.
    Cobb LM; Nolan J; Hacker T
    Int J Radiat Oncol Biol Phys; 1992; 22(4):655-9. PubMed ID: 1544833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of 14C-misonidazole as a probe for hypoxic cells in a murine tumor model.
    Ikeda H; Takahashi I; Yonome I; Mitsuhashi N; Niibe H
    Anticancer Res; 1998; 18(1A):241-5. PubMed ID: 9568084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nitroimidazole sensitizers on in vitro glycolytic metabolism of hypoxic squamous cell carcinoma.
    Minn H; Clavo AC; Fisher SJ; Wahl RL
    Acta Oncol; 2000; 39(2):199-205. PubMed ID: 10859011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
    Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA
    Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misonidazole binding in SCCVII tumors in relation to the tumor blood supply.
    Olive PL; Durand RE
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):755-61. PubMed ID: 2921174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misonidazole and other hypoxia markers: metabolism and applications.
    Franko AJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1195-202. PubMed ID: 3528089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
    Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
    Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
    Ling LL; Sutherland RM
    Br J Cancer; 1986 Dec; 54(6):911-7. PubMed ID: 3801286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo.
    Maxwell AP; MacManus MP; Gardiner TA
    Gastroenterology; 1989 Nov; 97(5):1300-3. PubMed ID: 2792663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splanchnic tissues undergo hypoxic stress during whole body hyperthermia.
    Hall DM; Baumgardner KR; Oberley TD; Gisolfi CV
    Am J Physiol; 1999 May; 276(5):G1195-203. PubMed ID: 10330010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA; Adomat H; Chaplin DJ; Farrell NP
    Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3H-misonidazole labeling and viability of hypoxic cells in the sandwich system, an in vitro tumor analogue.
    Hlatky L; Ring CS; Sachs RK
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):143-53. PubMed ID: 2912936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
    Born JL; Hadley WM
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.